: originates at one site, travels intravascularly to point of impact (90% originate in deep leg veins)
thromboembolus
: term usually used because it is difficult to distinguish a thrombus from an embolus
Epidemiology
: pulmonary embolism is the most common and most significant form of pulmonary vascular disease
3rd most common cause of death in the US; sole or contributing cause in 5-15% of adult deaths in acute hospitals
found in 40-50% of patients at autopsy
Pathogenesis
– saddle embolus: cast of the deep veins that obstructs the RV outflow tract and both main pulmonary aa
cardiovascular collapse
: can follow submassive embolum when histamine, serotonin and other substances released by platelets cause reflex bronchial and bronchiolar constriction Þ Ý V/Q mismatch; rarely occurs with <40% obstruction
insidious pulmonary HTN or cor pulmonale
can result from emboli to more peripheral pulmonary aa
Organization of Emboli
: sequence of changes after impaction occurs – allows for dating of the embolus
1-3 days – little reaction between embolus and vascular endothelium
3-8 days – endothelium has overgrown the clot, and endothelial cells have migrated into the embolus
8-10 days – fibroblasts, hemosiderin-filled macrophages, capillaries transversing the clot
3-4 wks – formation of collagen fibers in clot
final organization
may have several appearances: it may be an eccentric intimal fibrous plaque within the pulmonary artery, or it may be recanalized; if recanalized lumens are large, it appears as a fibrous intravascular web
Healing of Infarction
: acute ischemic necrosis occurs in 10% of embolus patients, patients with LV failure are at risk
extensive collateral flow in the lung is protective and is the reason why it is not more than 10%
progression
: initially, there is congestion of capillaries distal to obstruction, due to intrapulmonary collateral flow; if collateral flow is insufficient, ischemic damage causes leakage of blood into airspaces (this transient pulmonary hemorrhage is called the stage of incipient infarction and represents a stage where necrosis is still reversible); if ischemia persists, necrosis continues, and a scar eventually forms
Prognosis
: depends on the size Þ death due solely to obstruction occurs when >70% of pulmonary flow is blocked
Other Types of Emboli
:
bone marrow
: often follow closed-chest cardiac massage
fat emboli
: often occlude small pulmonary arteries following trauma; produce symptoms of respiratory failure
tumor embolization
: may induce thrombosis or endarteritis obliterans
foreign material
: from degenerating intravascular prosthetics or catheters (usually insignificant); filler substances with injectable drugs can induce a granulomatous reaction
Pulmonary Hypertension
(1) Hypoxia-Induced Pulmonary HTN
–hypoxiaÞ pulmonary vasoconstriction in an attempt to shunt blood away from underventilated areas; chronic hypoxia Þ hypertrophy of smooth muscle in all pulmonary vessels, even non-muscular
this is the primary mechanism of pulmonary hypertension in altitude exposure, hypoventilation, cystic fibrosis, COPD
(2) Pulmonary Hypertension Associated with an Anatomic Left-Right Shunt
in patients with congenital heart disease, pulmonary HTN starts early, and leads to mortality if the defect is uncorrected
Pathogenesis
– the left-right shunt leads to increased pulmonary pressures
initially there is proliferation and hypertrophy of smooth muscle in all vessels (same as in hypoxic state)
chronic
Ý pressure Þ endothelial proliferation and then concentric, laminar, intimal fibrosis (may occlude lumen)
fibrinoid necrosis may follow and is due to intense spastic contraction of medial smooth muscle
plexiform and dilatation lesions: probably begins as focal arteritis with thrombosis and recanalization; ends up as a complex small vascular channel in an aneurysmally dilated arterial segment with dilation distally
Prognosis
: following surgical correction of the lesion, prognosis depends mostly on the severity of the pulmonary HTN
arteritis or plexiform lesions predicts a poor prognosis
(3) Pulmonary Edema and Pulmonary Venous Hypertension
fluid can enter the lung via Starling forces at the level of the capillary, arteriolar or small venule
tight junctions in the alveolar epithelium restrict fluid transport, so fluid in the intravascular space drains to lymphatics
lymphatics run along the bronchovascular structure and in the visceral pleura and drain into systemic veins
High Pressure Edema
: usually secondary to LV failure; grossly, the lungs are heavy, dark blue-red with a frothy fluid;
interlobular septa are widened and this shows up as Kerley B lines on CXR
early changes: interstitial edema (perivascular cuffing - clear area around vessels and bronchi), dilated lymphatics
later: edema spills into alveolar compartment and is seen as eosinophilic material; fibrin and RBCs may be present
gross appearance: brown induration secondary to hemosiderin-laden macrophages (heart failure cells)
interlobular septa are thick and fibrotic; arteries also may be fibrotic
smooth muscle hypertrophy makes veins look like arteries
(4) Permeability Pulmonary Edema
– characteristic of ARDS
intravascular hydrostatic pressure is normal, but injury to the endothelium destroys its integrity
manifests as intercellular gaps, cell swelling, membrane blisters, necrosis